Search Results for: fda

8 simple reasons not to get an unlicensed stem cell treatment part 2: lack of follow-up

/ / 2 Comments

I’m doing a series of posts on straightforward reasons why patients should not get unlicensed stem cell treatments. Part 1 of the series was on the risk of losing medical insurance coverage. Today is part 2, which is focused on a serious failing of many for-profit, point-of-care stem cell clinics selling unlicensed treatments: lack of […]

8 simple reasons not to get an unlicensed stem cell treatment part 2: lack of follow-up Read More »

Are iPS cells being rushed to the clinic or has their time come?

/ / 2 Comments

The iPS cell field has run fast and furious over the past 6 years reaching a big milestone surprisingly quickly on Monday with Shinya Yamanaka winning the Nobel Prize. But is  the field going too fast? In August I argued that iPS cells are not quite ready for primetime (i.e. clinical trial studies). Now in

Are iPS cells being rushed to the clinic or has their time come? Read More »

Stem cells for COPD including emphysema: are we there yet?

/ / 3 Comments

Chronic obstructive pulmonary disease (COPD) is a relatively common, often debilitating illness, which has a major impact on the people of the world. In the U.S. alone, COPD costs the country almost $50 billion a year not to  mention untold suffering. Most of us know someone who has COPD. COPD is an umbrella term that

Stem cells for COPD including emphysema: are we there yet? Read More »

Stem cell shootout at the Texas Trib Festival including Celltex

/

The Texas Tribune held a liveblog regarding Health & Human Services at festival they were sponsoring. A particularly testy, interesting exchange on stem cells occurred (see starting around 2:51PM)  involving Andrea Ferrenz of Celltex and Dr. Leigh Turner of University of Minnesota as well as Texas State Rep. Rick Hardcastle and David Bales of Texans

Stem cell shootout at the Texas Trib Festival including Celltex Read More »

Stem Cell Biotech Advanced Cell Technology (ACT) gets $35 million

/ / 4 Comments

Advanced Cell Technology (ACT; stock symbol ACTC) announced that it has secured $35 million in funding from investment company, Lincoln Park Capital. The press release quotes CEO Gary Rabin: “We are most pleased about this financing agreement, as it has a number of notable benefits for the company,” commented Gary Rabin, chairman and CEO of

Stem Cell Biotech Advanced Cell Technology (ACT) gets $35 million Read More »

Intriguing interview with Robin Young, Organizer of Houston Stem Cell Summit

/ / 2 Comments

Next month will be the 1st Houston Stem Cell Summit organized by Robin Young, who also organizes the New York Stem Cell Summit. I’ve been a bit tough on this meeting for a perceived lack of diversity in their program of speakers. I interviewed Robin Young (RY) about the meeting and found his answers quite interesting

Intriguing interview with Robin Young, Organizer of Houston Stem Cell Summit Read More »

Houston stem cell meeting lacks diversity & risks falling to groupthink

/ / 1 Comment

Next month there is going to be a new stem cell meeting taking place. The 1st Annual Houston Stem Cell Summit. The primary sponsor is Celltex. I’d encourage everyone to go, but I’m not so sure it’d be worth it. Why? I’m always glad to see another stem cell meeting and this one is surely unique in

Houston stem cell meeting lacks diversity & risks falling to groupthink Read More »